Editorial Images

US-HEALTH-VIRUS-PHARMACEUTICAL-VACCINES

The Emergent BioSolutions plant, a manufacturing partner for Johnson & Johnson's Covid-19 vaccine, in Baltimore, Maryland, on April 9, 2021. - Deliveries of the Johnson & Johnson coronavirus vaccine in the US are set to drop off sharply next week, US health authorities said Friday, stoking further unease about the pharmaceutical giant's production abilities after it emerged that a batch of some 15 million doses had been accidentally spoiled at the plant. (Photo by SAUL LOEB / AFP) (Photo by SAUL LOEB/AFP via Getty Images)
US-HEALTH-VIRUS-PHARMACEUTICAL-VACCINES
Embed

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Italy, Spain, Canada (not Quebec). Restricted editorial rights elsewhere, please call local office.
Credit:
SAUL LOEB / Contributor
Editorial #:
1232202654
Collection:
AFP
Date created:
April 09, 2021
License type:
Release info:
Not released. More information
Source:
AFP
Barcode:
AFP
Object name:
AFP_97N9FU
Max file size:
5518 x 3679 px (18.39 x 12.26 in) - 300 dpi - 5 MB